Samuel C. Blackman - HEAD OF R&D at Day One Biopharmaceuticals, Inc.

Issuer-level insider activity

Role
Head Of R&D
Issuer ticker
DAWN
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Samuel C. Blackman since 13 Sep 2025

Reported holdings for Samuel C. Blackman in Day One Biopharmaceuticals, Inc.

Form 4 holding HEAD OF R&D

Day One Biopharmaceuticals, Inc.

Security class
Restricted Stock Unit (RSU)
Shares / value
84,876
Estimated value
$1,364,696
Report date
15 May 2024
Price
$16.08
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding HEAD OF R&D

Day One Biopharmaceuticals, Inc.

Security class
Restricted Stock Unit (RSU)
Shares / value
72,752
Estimated value
$961,068
Report date
15 Nov 2024
Price
$13.21
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding HEAD OF R&D

Day One Biopharmaceuticals, Inc.

Security class
Stock Option (right to buy Common Stock)
Shares / value
148,000
Estimated value
Report date
05 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Samuel C. Blackman in Day One Biopharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .